MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy

    Y. Saitoh, M. Miyazaki, A. Tsuru, Y. Takahashi (Kodaira, Tokyo, Japan)

    Objective: To investigate whether REM sleep without atonia (RWA) is associated with sleep architecture in patients with multiple system atrophy (MSA). Background: In MSA patients,…
  • MDS Virtual Congress 2020

    Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial

    M. Dale, B. Brumbach, A. Hiller (Portland, OR, USA)

    Objective: Amantadine anecdotally improves gait and balance in PSP, potentially by increasing alertness, but there are no definitive data to support this observation. We investigated…
  • MDS Virtual Congress 2020

    Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism

    D.T Akramova (Tashkent, Uzbekistan)

    Objective: It is known that, in vascular parkinsonism (VP) and Parkinson’s disease (PD) it is observed shortening of steps, bradikinesia, oligokinesia, gait disorders and also…
  • MDS Virtual Congress 2020

    May Safinamide have a Role in Atypical Parkinsonism? A Retrospective Study in Clinical Practice

    F. Rodríguez Jorge, A. Beltrán Corbellini, J.L Chico García, P. Parra Díaz, P. Pérez Torre, B. Baena Álvarez, I. Parées Moreno, J.L López-Sendón, J.C Martínez Castrillo, A. Alonso Cánovas, S. Fanjul Arbós (Madrid, Spain)

    Objective: To evaluate efficacy and safety of safinamide in atypical parkinsonian syndromes. Background: Safinamide (50-100 mg) has proved efficacy as an add-on treatment to levodopa…
  • MDS Virtual Congress 2020

    Mutations of COX20 affect the assembly and function of complex IV causing early onset ataxia, dystonia and neuropathy

    Y.M Liu, P.Z Li, DD. Guo, H.B LV, Y.L Zhang (Jinan, China)

    Objective: To find the causes of an early onset complex movement disorder in two sisters from a non-consanguineous family, and confirm the COX20 variants responsible for such mitochondrial…
  • MDS Virtual Congress 2020

    Clinical progression of Parkinson’s disease: insights from the NINDS common data elements

    M. Lewis, E. Harkins, E. Lee, C. Stetter, B. Snyder, T. Corson, G. Du, L. Kong, X. Huang (Hershey, PA, USA)

    Objective: To synchronize data collection, the National Institute of Neurological Disorders and Stroke recommended Common Data Elements (CDEs) for use in Parkinson’s disease (PD) research.…
  • MDS Virtual Congress 2020

    Home validation of a smartphone-based tapping task to assess medication responsiveness in Parkinson’s disease

    S. Broeder, R. Bussels, S. Vanden Schoor, G. Roussos, J-J. Orban deXivry, A. Nieuwboer (Leuven, Belgium)

    Objective: To validate a timed tapping task (TTT) on a smartphone to ascertain differences in OFF- and ON-phases in Parkinson’s disease (PD) in the home…
  • MDS Virtual Congress 2020

    The impact of motor and non-motor symptoms on walking capacity in people with Parkinson’ disease

    H. Khalil, R. Rayhan, A. Al-Sharman, A. Aburub, K. El-Salem (Irbid, Jordan)

    Objective: This study aimed to evaluate the motor and non-motor factors associated with walking capacity in people with Parkinson’s disease (PwPD). Background: Walking over short…
  • MDS Virtual Congress 2020

    Do improvements to primary symptoms from sensory training differ in Parkinson’s disease ON vs. OFF dopaminergic medications?

    K. Sangarapillai, B. Norman, E. Beck, Q. Almeida (Waterloo, ON, Canada)

    Objective: Investigate whether the effects of sensory training differ ON vs. OFF medication in Parkinson’s disease using the Unified Parkinson’s Disease Rating Scale (UPDRS-III). Background:…
  • MDS Virtual Congress 2020

    Quantifying the incremental burden of advancing Parkinson’s disease in patients meeting the “5-2-1” Criteria: Results from an international dataset from G7 countries

    I. Malaty, M. Skorvanek, A. Alobaidi, K. Onuk, L. Bergmann, S. Femia, M. Lee, E. Jones, J. Pike, P. Martinez-Martin (Gainesville, FL, USA)

    Objective: Quantify the incremental clinical and humanistic burden of advancing Parkinson’s disease (PD) in patients meeting the “5-2-1” criteria. Background: The burden of PD worsens…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley